• Reproductive health of women with multiple sclerosis: the current state of the problem (Literature review)

Reproductive health of women with multiple sclerosis: the current state of the problem (Literature review)

HEALTH OF WOMAN.2017.1(117):158–161

Nehrych O., Pyrohova V.
Lviv national medical University named Danylo Galitsky

The article deals with current issues in research of reproductive health in women with multiple sclerosis.

Key words: reproductive health, multiple sclerosis, sexual dysfunction, pregnancy.


1. Belova A, Kachalina T, Krupin V. 2010. Multiple sclerosis and pregnancy. Neurological Journal. 6:4-10.

2. Nehrych T, Shorobura M, Negrych N. 2013. Multiple sclerosis in pregnancy and impact of pathogenetic treatment on fetus and newborn. International Neurological Journal. 1:11-16.

3. Orynchak LB. 2015. Influence of the age of menarche and marital status in female patients with multiple sclerosis on clinical characteristics of this disease. International Neurological Journal. 3:151-156.

4. Radzikhovska N, Sokolova L. 2014. Sexual dysfunction in patients with multiple sclerosis of different severity and duration. Ukrainian Neurological Journal. 1:75-80.

5. Statistical data. 2016. Center of Medical Statistics. Retrieved from http: medstat.gov.ua/ukr/statreports.html  

6. Airas L, Jalkanen A, Alanen A. 2011. Breast- feeding, postpartum and prepregnancy disease activity in multiple sclerosis. Neurology. 75(5):474-476. https://doi.org/10.1212/WNL.0b013e3181eb5860; PMid:20679640

7. Airas L. 2015. Hormonal and gender-related immune changes in multiple sclerosis. Acta Neurol Scandinavica. 132:62-70. https://doi.org/10.1111/ane.12433; PMid:26046561

8. Airas L, Kaaja R. 2012. Pregnancy and multiple sclerosis. Obstetric Med. 5:94-97. https://doi.org/10.1258/om.2012.110014; PMid:27582863 PMCid:PMC4989704

9. Alonso A, Jick S, Olek M et al. 2005. Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol. 62(9):1362–1365. https://doi.org/10.1001/archneur.62.9.1362; PMid:16157743

10. Alonso A, Hernan M. 2008. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology. 71(2):129–135. https://doi.org/10.1212/01.wnl.0000316802.35974.34; PMid:18606967 PMCid:PMC4109189

11. Amato M, Portaccio E, Ghezzi A et al. 2010. Pregnancy and fetal outcomes after interferon-b exposure in multiple sclerosis. Neurology. 75:1794–1802. https://doi.org/10.1212/WNL.0b013e3181fd62bb; PMid:21079181

12. Amato M, Portaccio E. 2015. Fertility, Pregnancy and Childbirth in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs. CNS Drugs. 29(3):207-220. https://doi.org/10.1007/s40263-015-0238-y; PMid:25773609

13. Bamford C, Sibley W, Laguna J. 1978. Anesthesia in multiple sclerosis. Can J Neurol Sci. 5:41-44. PMid:647496

14. Borchers A, Naguwa S, Keen C et al. 2010. The implications of autoimmunity and pregnancy. J Autoimmun. 34(3):287-299. https://doi.org/10.1016/j.jaut.2009.11.015; PMid:20031371

15. Bronner G, Elrran E. 2010. Female sexuality in multiple sclerosis: the multidimensional nature of the problem and the intervention. Acta Neurol Scandinavica. 121(5):289-301. https://doi.org/10.1111/j.1600-0404.2009.01314.x; PMid:20070276

16. Bove R, Chitnis T. 2014. The role of gender and sex hormones in determining the onset and outcome of multiple sclerosis. Mult Scler. 20(5):520-526. https://doi.org/10.1177/1352458513519181; PMid:24561324

17. Confavreux C, Hutchinson M, Hours M et al. 1998. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med. 339(5):285-291. https://doi.org/10.1056/NEJM199807303390501; PMid:9682040

18. Correale J, Farez M, Ysrraelit M. 2012. Increase in multiple sclerosis activity after assisted reproduction technology. Ann Neurol. 72(5):682-694. https://doi.org/10.1002/ana.23745; PMid:23034952

19. Dahl J, Myhr K, Daltveit A et al. 2005. Pregnancy, delivery, and birth outcome in women with multiple sclerosis. Neurology. 65:1961–1963. https://doi.org/10.1212/01.wnl.0000188898.02018.95; PMid:16380620

20. D’hooghe M, Haentjens P, Nagels G et al. 2012. Menarche, oral contraceptives, pregnancy and progression of disability in relapsing onset and progressive onset multiple sclerosis. J Neurol. 259(5):855-861. https://doi.org/10.1007/s00415-011-6267-7; PMid:21993617

21. Heras De L, Andres De C, Tellez N et al. 2007. Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population. Mult Scler. 13:981-984. https://doi.org/10.1177/1352458507077896; PMid:17623725

22. Demirkiran M, Sarica Y, Uguz S et al. 2006. Multiple sclerosis patients with and without sexual dysfunction: are there any differences? Mult Scler. 12:209–214. https://doi.org/10.1191/135248506ms1253oa

23. Falaschi P, Martocchia, Proietti A et al. 2001. High incidence of hyperandrogenism-related clinical signs in patients with multiple sclerosis. Neuro Endocrinol Lett. 22(4):248-250. PMid:11524631

24. Gava G, Bartolomei I, Costantino A. 2014. Long-term influence of combined oral contraceptive use on the clinical course of relapsing–remitting multiple sclerosis. Fertil Steril. 102(1):116-122. https://doi.org/10.1016/j.fertnstert.2014.03.054; PMid:24794311

25. Finkelsztejn A, Brooks J, Paschoal F Jr et al. 2011. What can we really tell women with multiple sclerosis regarding pregnancy? A systematic review and meta-analysis of the literature. BJOG. 118(7):790–797. https://doi.org/10.1111/j.1471-0528.2011.02931.x

26. Gilli F, Lindberg R, Valentino P et al. 2010. Learning from nature: pregnancy changes the expression of inflammation-related genes in patients with multiple sclerosis. PLoS One. 5(1):8962. https://doi.org/10.1371/journal.pone.0008962; PMid:20126412 PMCid:PMC2813302

27. Grinsted L, Heltberg A, Hagen C et al. 1989. Serum sex hormone and gonadotropin concentrations in premenopausal women with multiple sclerosis. J Intern Med. 226(4):241. https://doi.org/10.1111/j.1365-2796.1989.tb01387.x; PMid:2809499

28. Hellwig K, Correale J. 2013. Artificial reproductive techniques in multiple sclerosis. Clin Immunol. 149(2):219-224. https://doi.org/10.1016/j.clim.2013.02.001; PMid:23507401

29. Hellwig K, Schimrigk S, Beste C et al. 2009. Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur Neurol. 61(2):65-68. https://doi.org/10.1159/000177937; PMid:19039223

30. Hernan M, Hohol M, Olek M et al. 2000. Oral contraceptives and the incidence of multiple sclerosis. Neurology. 55(6):848–854. https://doi.org/10.1212/WNL.55.6.848; PMid:10994007

31. Holmqvist P, Hammar M, Landtblom A et al. 2010. Age at onset of multiple sclerosis is correlated to use of combined oral contraceptives and childbirth before diagnosis. Fertil Steril. 94(7):2835-2837. https://doi.org/10.1016/j.fertnstert.2010.06.045; PMid:20807659

32. Holmqvist P, Hammar M, Landtblom A et al. 2009. Symptoms of multiple sclerosis in women in relation to cyclical hormone changes. Eur J Contracept Reprod Health Care. 14(5):365–370. https://doi.org/10.3109/13625180903137329; PMid:19916763

33. Kempe P, Hammar M, Brynhildsen J. 2015. Symptoms of multiple sclerosis during use of combined hormonal contraception. Eur J Obstet Gynecol Reprod Biol. 193:1-4. https://doi.org/10.1016/j.ejogrb.2015.06.030; PMid:26196655

34. Jalkanen A, Alanen A, Airas L. 2010. Pregnancy outcome in women with multiple sclerosis – results from a prospective nationwide study in Finland. Mult Scler. 16:950-955. https://doi.org/10.1177/1352458510372629; PMid:20542921

35. Laumann E, Glasser D, Neves R et al. 2009. A population-based survey of sexual activity, sexual problems and associated help-seeking behavior patterns in mature adults in the United States of America. Int J Impot Res. 21:171-178. https://doi.org/10.1038/ijir.2009.7; PMid:19242482

36. Michel L, Foucher Y, Vukusic et al. 2013. Increased risk of multiple sclerosis relapse after in vitro fertilisation. J Neurol Neurosurg Psychiatry. 83(8):796–802. https://doi.org/10.1136/jnnp-2012-302235; PMid:22693287

37. Combe Mc P, Greer J. 2012. Female reproductive issues in multiple sclerosis. Mult Scler. 19(4):392–402. https://doi.org/10.1177/1352458512452331; PMid:22733837

38. Moreira E, Glasser D, Nicolosi A et al. 2008. Sexual problems and help-seeking behaviour in adults in the United Kingdom and continental Europe. BJU Int. 101:1005-1011. https://doi.org/10.1111/j.1464-410X.2008.07453.x; PMid:18261155

39. Mueller B, Zhang J, Critchlow C. 2002. Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis. Am J Obstet Gynecol. 186:446-452. https://doi.org/10.1067/mob.2002.120502; PMid:11904605

40. Neill J, Knobil E. 2005. Knobil and Neill’s physiology of reproduction. New York: Academic Press.

41. Orton S, Hererra B, Yee I et al. 2006. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 5(11):932–936. https://doi.org/10.1016/S1474-4422(06)70581-6

42. Ortona E, Pierdomonici M, Maselli A. 2016. Sex-based differences in autoimmune diseases. Annali dell'Istituto Superiore di Sanità. 52(2):205-212. PMid:27364395

43. Pasto L, Portaccio E, Ghezzi A et al. 2012. Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study. BMC Neurol. 12:165. https://doi.org/10.1186/1471-2377-12-165; PMid:23276328 PMCid:PMC3544735

44. Patti F, Cavallaro T, Fermo Lo S. 2008. Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis? J Neurol. 255:1250-1253. https://doi.org/10.1007/s00415-008-0909-4; PMid:18677640

45. Pierdominici M, Maselli A, Colasanti T. 2010. Estrogen receptor pro les in human peripheral blood lymphocytes. Immunol Lett. 132(1-2):79-85. https://doi.org/10.1016/j.imlet.2010.06.003; PMid:20542061

46. Portaccio E, Ghezzi A, Hakiki B et al. 2011. Breastfeeding is not related to postpartum relapses in multiple sclerosis. Neurology. 77(2):145-150. https://doi.org/10.1212/WNL.0b013e318224afc9; PMid:21734184

47. Portaccio E, Ghezzi A, Hakiki B et al. 2014. Postpartum relapses increase the risk of dis- ability progression in multiple sclerosis: the role of disease modifying drugs. J Neurol Neurosurg Psychiatry. 85(8):845-850. https://doi.org/10.1136/jnnp-2013-306054; PMid:24403285

48. Poser S, Raun N, Wikstrom J et al. 1979. Pregnancy, oral contraceptives and multiple sclerosis. Acta Neurol Scand. 59(2-3):108-118. https://doi.org/10.1111/j.1600-0404.1979.tb02917.x

49. Prieto G, Rosenstein Y. 2006. Oestradiol potentiates the suppressive function of human CD4/CD25 regulatory T cells by promoting their proliferation. Immunology. 118(1):58-65. https://doi.org/10.1111/j.1365-2567.2006.02339.x; PMid:16630023 PMCid:PMC1782269

50. Ramagopalan S, Valdar W, Criscuoli M et al. 2009. Age of puberty and the risk of multiple sclerosis: a population based study. Eur J Neurol. 16(3):342-347. https://doi.org/10.1111/j.1468-1331.2008.02431.x; PMid:19170744

51. Rosen R. 2002. Assessment of female sexual dysfunction: review of validated methods. Fertil Steril. 77(4):89–93. https://doi.org/10.1016/S0015-0282(02)02966-7

52. Salminen H, Leggett H, Boggild M. 2010. Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes. J Neurol. 257:2020-2023. https://doi.org/10.1007/s00415-010-5652-y; PMid:20625758

53. Sandberg-Wollheim M, Alteri E, Moraga Stam M et al. 2011. Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy. Mult Scler. 17:423-430. https://doi.org/10.1177/1352458510394610; PMid:21220368

54. Sandberg-Wollheim M, Frank D, Goodwin T. 2005. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis. Neurology. 65(6):802-806. https://doi.org/10.1212/01.wnl.0000168905.97207.d0; PMid:16093457

55. Sena A, Couderc R, Vasconcelos J et al. 2012. Oral contraceptive use and clinical outcomes in patients with multiple sclerosis. J Neurol Sci. 317(1-2):47-51. https://doi.org/10.1016/j.jns.2012.02.033; PMid:22459356

56. Shelly S, Boaz M, Orbach H. 2012. Prolactin and autoimmunity. Autoimmun Rev. 11(6-7): 465-470. https://doi.org/10.1016/j.autrev.2011.11.009; PMid:22155203

57. Stenager E, Stenager E, Jensen K. 1996. Sexual function in multiple sclerosis: a 5-year follow-up study. Ital J Neurol Sci. 17:67-69. https://doi.org/10.1007/BF01995711; PMid:8742990

58. Sloka J, Pryse-Phillips W, Stefanelli M. 2006. The relation between menarche and the age of first symptoms in a multiple sclerosis cohort. Mult Scler. 12(3):333-339. https://doi.org/10.1191/135248506ms1267oa; PMid:16764348

59. Tan I, Peeva E, Zandman-Goddard G. 2015. Hormonal modulation of the immune system – A spotlight on the role of progestagens. Autoimmun Rev. 14(6):536-542. https://doi.org/10.1016/j.autrev.2015.02.004; PMid:25697984

60. Thone J, Kollar S, Nousome D. 2015. Serum anti-Mullerian hormone levels in reproductive- age women with relapsing–remitting multiple sclerosis. Mult Scler. 21(1):41-47. https://doi.org/10.1177/1352458514540843; PMid:25145691

61. Thorogood M, Hannaford P. 1998. The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstetr Gynaecol. 105(12):1296-1299. https://doi.org/10.1111/j.1471-0528.1998.tb10008.x; PMid:9883921

62. Trigunaite A, Dimo J, Jorgensen T. 2015. Suppressive effects of androgens on the immune system. Cell Immunol. 294(2):87-94. https://doi.org/10.1016/j.cellimm.2015.02.004; PMid:25708485

63. Voskuhl R, Wang H. 2016. Estriol combined with glatiramer acetate for women with relapsing-remit- ting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 15(1):35-46. https://doi.org/10.1016/S1474-4422(15)00322-1

64. Vukusic S, Hutchinson M, Hours M. 2004. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain. 127(6):1353-1360. https://doi.org/10.1093/brain/awh152

65. Zandman-Goddard G, Peeva E, Shoenfeld Y. 2007. Gender and autoimmunity. Autoimmun Rev. 6:366-372. https://doi.org/10.1016/j.autrev.2006.10.001; PMid:17537382

Содержание журнала Full text of article